All
Research
Education
Araştırma
Eğitim
Business
Çözümler
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Oturum Aç
Bahram Sharif-Askari has not added Biography.
If you are Bahram Sharif-Askari and would like to personalize this page please email our Author Liaison for assistance.
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines.
Breast cancer research and treatment Nov, 2018 | Pubmed ID: 30039287
Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.
Scientific reports Jul, 2019 | Pubmed ID: 31363127
PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin.
Frontiers in bioscience (Landmark edition) Mar, 2023 | Pubmed ID: 37005765
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia.
Blood advances Oct, 2024 | Pubmed ID: 39093953
Lady Davis Institute for Medical Research
Victor Gife1,2,
Bahram Sharif-Askari3,
Anavasadat Sadr Hashemi Nejad1,2,
Raquel Aloyz3,4,5,
Laura Hulea1,2,6,
François E. Mercier3,4
1, Maisonneuve-Rosemont Hospital Research Centre,
2Department of Biochemistry and Molecular Medicine, University of Montreal,
3, Lady Davis Institute for Medical Research,
4Department of Medicine, McGill University,
5Gerald Bronfman Department of Oncology, McGill University,
6Department of Medicine, University of Montreal
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
JoVE Sitemap
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır